课题基金 / 基金详情

Development of drugs targeting liver fibrosis by modulation of protein/lipid glycosylation

Development of drugs targeting liver fibrosis by modulation of protein/lipid glycosylation
通过调节蛋白质/脂质糖基化开发针对肝纤维化的药物
批准号:
18K19530
负责人:
Sakamoto Naoya
金额:
$3.99万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
财政年份:
2018
资助国家:
日本
项目状态:
已结题
起止时间:
2018-06-29 至 2020-03-31
关键词:

项目摘要

项目成果

Sakamoto Naoya的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/acs.analchem.9b03617
发表时间: 2019-11-05
期刊: ANALYTICAL CHEMISTRY
影响因子: 7.4
作者: [Hanamatsu, Hisatoshi, Nishikaze, Takashi, Sakamoto, Naoya]
通讯作者: Sakamoto, Naoya
DOI: 10.1021/acs.jproteome.9b00232
发表时间: 2019-08-01
期刊: JOURNAL OF PROTEOME RESEARCH
影响因子: 4.4
作者: [Kobayashi, Takashi, Ogawa, Koji, Sakamoto, Naoya]
通讯作者: Sakamoto, Naoya
Targeting the glycosylated structure of liver tissue stromal proteins to form the basis for glycosylation drug discovery for liver fibrosis.
  • 批准号:
    20K21592
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
  • 资助金额:
    $4.16万
  • 财政年份:
    2020
  • 负责人:
    Sakamoto Naoya
  • 依托单位:
Comprehensive screening of miviroenvirinmental factors that affect liver fibrosis
  • 批准号:
    19H03630
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.23万
  • 财政年份:
    2019
  • 负责人:
    Sakamoto Naoya
  • 依托单位:
Search for new cell- or small molecule-based therapies to promote regression of liver cirrohsis
  • 批准号:
    16H05282
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.07万
  • 财政年份:
    2016
  • 负责人:
    Sakamoto Naoya
  • 依托单位:
Establishment of the model of intestinal and gastric type gastric cancer using CRISPR/Cas9 and organoid
  • 批准号:
    16H06999
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
  • 资助金额:
    $1.91万
  • 财政年份:
    2016
  • 负责人:
    Sakamoto Naoya
  • 依托单位:
海外基金